Marine indole alkaloids: potential new drug leads for the control of depression and anxiety.
Kochanowska-Karamyan
Anna J
AJ
Department of Pharmacognosy, and the Research Institute of Pharmaceutical Sciences, School of Pharmacy, the University of Mississippi, University, Mississippi 38677, USA.
Hamann
Mark T
MT
D000818:Animals; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy*; D003863:Depression / Q000188:drug therapy*; D006801:Humans; D026121:Indole Alkaloids / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D009792:Oceans and Seas; D011985:Receptors, Serotonin / Q000378:metabolism; D012623:Seawater; D017366:Serotonin Receptor Agonists / Q000494:pharmacology / Q000627:therapeutic use; D014363:Tryptamines / Q000494:pharmacology / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D026121:Indole Alkaloids; D011985:Receptors, Serotonin; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C030820:tryptamine